Science that moves lives forward

Science that moves lives forward

We bridge the gap between bold medical ideas and real-world impact, advancing clinical research with precision and purpose.

At BCCC we partner with industry leaders, startups, and researchers to transform bold ideas into reliable clinical evidence – through hospital-backed trials, scientific rigor, and regulatory expertise that accelerate validation.

Clinical trials and in vitro diagnostics

We support the full journey of bringing new medicines, medical devices, and in-vitro diagnostics to market—combining practical experience with regulatory know-how to streamline each step from development to approval. BCCC also joins you to perform post-authorization and biomedical studies, among others.

Post-authorization and biomedical studies

Integrated services that drive research forward

We understand the pace and constraints of research-driven teams. Our flexible, responsive approach is built to support startups, biotech, medtech, and academic innovators from the ground up.

Why choose BCCC

Your innovation deserves a partner who understands the science and the path to approval.

A full-service CRO with deep expertise in clinical trials, regulatory strategy, and statistical consulting.
We combine agility and local insight with EU and US regulatory compliance to deliver reliable, accelerated results.
Our flexible collaboration model adapts to the needs of academic researchers, startups, and growing companies.

Partners and collaborators

News

Stay up to date with the latest news, research, and perspectives shaping clinical development and regulatory science.

DORAYA-HF OUS EFS study successfully completed across Europe under the coordination of the BCCC

Barcelona Clinical Coordinating Center (BCCC), serving as the European Authorized Representative of Revamp Medical Inc. and responsible for the coordination of study activities in Spain, announces the successful completion of the DORAYA-HF OUS EFS study evaluating the safety, feasibility, and clinical performance of the Doraya Catheter for the treatment of volume overload in patients hospitalized… Read more »

Read more

Barcelona Clinical Coordinating Center celebrates the successful completion of patient recruitment in the PRIMARY study

Barcelona Clinical Coordinating Center (BCCC), acting as the national coordinating contract research organization (CRO) for Spain, celebrates the successful completion of patient recruitment in the PRIMARY study evaluating the long-term safety and effectiveness of transcatheter edge-to-edge repair (TEER) compared with surgical repair in patients with primary degenerative mitral regurgitation. Sponsored by the National Institutes of… Read more »

Read more

BCCC Imaging Core Lab Contributes to Landmark Stroke Trial Published in JAMA 

The CHOICE-2 randomized clinical trial, coordinated by Hospital Clínic Barcelona and IDIBAPS, has been published in JAMA (Journal of American Medical Association). The study demonstrates that administering intra-arterial alteplase immediately after mechanical thrombectomy significantly improves functional outcomes in severe ischemic stroke. The centralized analysis of brain imaging data across the 14-site Spanish trial was conducted by the BCCC Imaging Core Lab.  Key Results  Among the 440 patients enrolled,… Read more »

Read more

The future of health is built by those bold enough to test it. We're here to help you prove it